English
Home > Products > Atropine

China Atropine Factory

Our growth depends within the innovative equipment, fantastic talents and repeatedly strengthened technology forces for Atropine,CAS NO 5908-99-6,5908-99-6,Atropine API, Our aim will be to assistance shoppers comprehend their goals. We've been earning good endeavours to obtain this win-win scenario and sincerely welcome you to definitely sign up for us.
Atropine, Our products are widely recognized and trusted by users and can meet continuously changing of economic and social needs. We welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!

Related Products

Hot Products

  • 2-(4-Fluorophenyl)Thiophene

    2-(4-Fluorophenyl)Thiophene

    2-(4-Fluorophenyl)Thiophene
    Molecular Formula: C10H7FS
    Formula Weight: 178.23
    CAS NO:58861-48-6
    Usage:Canagliflozin Intermediates​
  • all-trans-Retinol

    all-trans-Retinol

    Product Name:all-trans-Retinol
    Molecular Formula:C20H30O
    Molecular Weight:286.45
    CAS Registry Number:68-26-8
  • Boc-3-Hydroxy-1-adamantyl-D-glycine

    Boc-3-Hydroxy-1-adamantyl-D-glycine

    Product Name:Boc-3-Hydroxy-1-adamantyl-D-glycine
    Molecular Formula:C17H27NO5
    Molecular Weight:325.4
    CAS Registry Number:361442-00-4
  • Sodium carbonate

    Sodium carbonate

    Product Name:Sodium carbonate
    Molecular Formula:CH2O3.2Na
    Molecular Weight:105.99
    CAS Registry Number:497-19-8
  • Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate

    Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate

    Product Name:Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate
    Molecular Formula:C15H21NO8
    Molecular Weight:343.33
    CAS Registry Number:179688-26-7
  • Citric acid monohydrate

    Citric acid monohydrate

    Product Name:Citric acid monohydrate
    Molecular Formula:C6H10O8
    Molecular Weight:210.1388
    CAS Registry Number:5949-29-1
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

Atropine API

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept